MTAP is a promising target for cancer therapy.
EpidStrategies’ scientists Mina Suh, Naimisha Movva, and Sue Pastula have authored a new systematic literature review in Cancer Treatment and Research Communications. This… read more
EpidStrategies’ scientists Mina Suh, Naimisha Movva, and Sue Pastula have authored a new systematic literature review in Cancer Treatment and Research Communications. This… read more
Executive Orders issued since President Trump’s inauguration have eliminated all federal programs relating to environmental justice (EJ), including at EPA. Nevertheless, the need… read more
We are pleased to announce the addition of Timothy W. Robison, PhD, DABT, who has 29 years of experience at the US Food… read more
ToxStrategies’ scientists Jennifer Bare, Mandie Kramer, and Susan Borghoff are excited share their new paper on consumer product exposure to vinyl acetate monomer… read more
It is crucial to complete post-fire assessments before a home is reoccupied. ToxStrategies’ team of industrial hygienists are experienced in evaluating homes affected… read more
Dr. Naomi Sacks, Vice President, BlueRidge Life Sciences’ Pharmaceutical Commercialization division, is attending the annual meeting of ISPOR (The Professional Society for Health Economics… read more
In the United States, the most common childhood central nervous system cancer is pediatric low-grade glioma, but there are no standardized coding definitions… read more
Dr. Stephanie Kennedy is co-author on three posters regarding risk assessment strategies for microplastics and is looking forward to attending scientific platform and… read more